What Is Skyrizi Used For? A Detailed Overview

Skyrizi is a prescription medication used to treat moderate to severe plaque psoriasis in adults. This chronic skin condition is characterized by red, scaly patches that can be itchy and painful. Skyrizi works by targeting specific proteins in the body that are involved in the inflammatory process that leads to psoriasis.

Skyrizi is a valuable treatment option for individuals suffering from moderate to severe plaque psoriasis. This medication is specifically designed to address the underlying causes of psoriasis, providing relief from symptoms such as redness, itching, and pain. By targeting specific proteins involved in the inflammatory process, Skyrizi helps to reduce inflammation and slow down the growth of skin cells, ultimately improving the skin symptoms associated with psoriasis.

In addition to its effectiveness in treating psoriasis, Skyrizi offers the convenience of at-home administration. This means that individuals can self-administer the medication using a prefilled syringe or pen device, under the guidance of their healthcare provider. This allows for greater flexibility and autonomy in managing the condition, while still receiving the necessary medical support and monitoring.

Skyrizi not only helps to improve the physical symptoms of psoriasis but can also have a positive impact on the overall quality of life for individuals with this condition. By providing relief from inflammation, itching, and pain, Skyrizi can help individuals feel more comfortable in their own skin and experience long-lasting remission of symptoms in some cases. If you are considering treatment with Skyrizi, it is important to consult with your healthcare provider to discuss the potential benefits and risks of this medication.

How Does Skyrizi Work?

Skyrizi contains the active ingredient risankizumab, which is a type of biologic therapy known as an interleukin-23 (IL-23) inhibitor. IL-23 is a protein that plays a key role in triggering the immune response that leads to psoriasis. By blocking IL-23, Skyrizi helps to reduce inflammation and slow down the growth of skin cells, which in turn helps to improve the symptoms of psoriasis.

Risankizumab targets specific proteins involved in the inflammatory process, providing targeted relief for psoriasis symptoms.
By blocking IL-23, Skyrizi helps to regulate the immune response that leads to psoriasis, ultimately reducing inflammation and improving skin symptoms.
The mechanism of action of Skyrizi helps to address the underlying causes of psoriasis, rather than just treating the symptoms, leading to more effective and long-lasting results.

Who Can Take Skyrizi?

Skyrizi is approved for use in adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is not recommended for use in children or adolescents under the age of 18. Before starting treatment with Skyrizi, your healthcare provider will assess your medical history and overall health to determine if this medication is right for you.

Skyrizi is specifically indicated for adults with moderate to severe plaque psoriasis who have not responded adequately to other treatments.
Before initiating treatment with Skyrizi, your healthcare provider will conduct a thorough evaluation to ensure that you are a suitable candidate for this medication.
Individuals under the age of 18 should not take Skyrizi, as its safety and efficacy in this population have not been established.

How Is Skyrizi Administered?

Skyrizi is given by injection under the skin (subcutaneous injection). The medication comes in a prefilled syringe or pen device that you can use at home. Your healthcare provider will show you how to properly administer the injection, and you may need to have regular blood tests while taking Skyrizi to monitor your response to treatment.

Skyrizi is administered via subcutaneous injection, allowing for convenient at-home administration.
Your healthcare provider will provide detailed instructions on how to properly administer the injection, ensuring that you are comfortable and confident in self-administering the medication.
Regular monitoring, including blood tests, may be necessary while taking Skyrizi to assess your response to treatment and adjust the dosage if needed.

What Are the Side Effects of Skyrizi?

Like all medications, Skyrizi can cause side effects in some people. Common side effects of Skyrizi may include:

Injection site reactions, such as redness, swelling, or itching
Upper respiratory infections
Headache
Fatigue
Diarrhea

It is important to report any side effects to your healthcare provider, as they can help manage these symptoms and adjust your treatment plan if needed.

Injection site reactions are common with Skyrizi and typically resolve on their own over time.
Upper respiratory infections may occur in some individuals taking Skyrizi, but are usually mild and temporary.
Headache, fatigue, and diarrhea are additional side effects that may occur with Skyrizi, but can often be managed with supportive care or adjustments to the treatment regimen.

How Long Does It Take for Skyrizi to Work?

Individual responses to Skyrizi can vary, but many people may start to see improvement in their psoriasis symptoms within the first few weeks of treatment. It is important to follow your healthcare provider’s instructions and continue taking Skyrizi as prescribed, even if you do not see immediate results. It may take several months for Skyrizi to reach its full effectiveness.

Some individuals may experience improvement in their psoriasis symptoms within a few weeks of starting treatment with Skyrizi, while others may require longer to see significant results.
Consistent adherence to the treatment regimen is essential for optimal outcomes with Skyrizi, even if initial improvements are not immediately apparent.
Your healthcare provider will monitor your progress and may adjust your treatment plan as needed to ensure that you are receiving the maximum benefit from Skyrizi.

What Are the Benefits of Skyrizi?

Skyrizi offers several benefits for individuals with moderate to severe plaque psoriasis, including:

Reduced inflammation and itching
Improved skin appearance and texture
Long-lasting remission of symptoms in some cases
Convenient at-home administration

By targeting a specific pathway in the immune system, Skyrizi provides targeted relief for psoriasis symptoms without affecting the entire immune system.

Skyrizi’s ability to target specific proteins involved in the inflammatory process helps to reduce inflammation and alleviate itching, providing relief from common symptoms of psoriasis.
Improved skin appearance and texture are additional benefits of Skyrizi, as the medication helps to slow down the excessive growth of skin cells associated with psoriasis.
In some cases, Skyrizi may lead to long-lasting remission of symptoms, allowing individuals to experience extended periods of relief from psoriasis flare-ups.

FAQ

What is Skyrizi used for?

Skyrizi is a prescription medication used to treat moderate to severe plaque psoriasis in adults.

How does Skyrizi work?

Skyrizi contains the active ingredient risankizumab, which is a type of biologic therapy known as an interleukin-23 (IL-23) inhibitor. By blocking IL-23, Skyrizi helps to reduce inflammation and slow down the growth of skin cells, which in turn helps to improve the symptoms of psoriasis.

Who can take Skyrizi?

How is Skyrizi administered?

Skyrizi is given by injection under the skin (subcutaneous injection) using a prefilled syringe or pen device. Your healthcare provider will show you how to properly administer the injection, and you may need to have regular blood tests while taking Skyrizi to monitor your response to treatment.